<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the 10-QSB
of DrugMax.com, Inc. for the 6 months ended September 30, 2000 and is qualified
in its entirety by reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> MAR-31-2001
<PERIOD-END> SEP-30-2000
<CASH> 5,475,136
<SECURITIES> 0
<RECEIVABLES> 10,872,282
<ALLOWANCES> 472,870
<INVENTORY> 9,262,283
<CURRENT-ASSETS> 29,000,928
<PP&E> 852,765
<DEPRECIATION> 133,343
<TOTAL-ASSETS> 54,857,181
<CURRENT-LIABILITIES> 21,417,815
<BONDS> 0
0
0
<COMMON> 6,419
<OTHER-SE> 32,038,589
<TOTAL-LIABILITY-AND-EQUITY> 54,857,181
<SALES> 67,862,991
<TOTAL-REVENUES> 67,862,991
<CGS> 65,495,437
<TOTAL-COSTS> 65,495,437
<OTHER-EXPENSES> 4,043,382
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 471,611
<INCOME-PRETAX> (2,147,439)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,147,439)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,147,439)
<EPS-BASIC> (0.34)
<EPS-DILUTED> (0.34)
</TABLE>